NT 10-K 1 wmti12b25123111.htm WOUND MANAGEMENT TECHNOLOGIES, INC. wmti12b25123111.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
 
NOTIFICATION OF LATE FILING
 
 
(CHECK ONE):
x Form 10-K
o Form 20-F
o Form 11-K
o Form 10-Q
o Form N-SAR
 
 
For Period Ended:
December 31, 2011
     
 
o Transition Report on Form 10-K
 
o Transition Report on Form 20-F
 
o Transition Report on Form 11-K
 
o Transition Report on Form 10-Q
 
o Transition Report on Form N-SAR
 
For the Transaction Period Ended:
 
  
             

 
READ INSTRUCTION (ON BACK PAGE) BEFORE PREPARING FORM. PLEASE PRINT OR TYPE.
NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS VERIFIED ANY INFORMATION CONTAINED HEREIN.
 
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
 
 
PART I - REGISTRANT INFORMATION
 
Wound Management Technologies, Inc.
Full Name of Registrant
 
 
Former Name if Applicable
 
777 Main Street, Suite 3100
Address of Principal Executive Office (Street and Number)
 
Fort Worth, Texas 76102
City, State and Zip Code
 
PART II - RULES 12b-25(b) AND (c)
 
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 
 o
 
(a)
   
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
   
 
 x
 
(b)
   
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and  
 
 o
 
(c)
   
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
   

 
 
 
 

 
 
PART III - NARRATIVE
 
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period.
 
The Registrant's Quarterly Report on Form 10-K for the period ending December 31, 2011 could not be filed within the prescribed time period because the report and financial statements could not be completed, then reviewed by the Company's independent auditor in time without unreasonable effort and expense.
 

 
PART IV - OTHER INFORMATION
 
(1)
Name and telephone number of person to contact in regard to this notification
 
 
Scott A. Haire
 
817
 
820-7080
 
(Name)
 
(Area Code)
 
(Telephone Number)
 
(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
x Yes
o No
   
 
(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
o Yes
 x No
 
 
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
 
   
             
 
 
   
Wound Management Technologies, Inc.
(Name of Registrant as Specified in Charter)
   
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
 
   
Date
March 29, 2012
 
By
/s/ Scott A. Haire
 
        Chief Executive Officer